Page last updated: 2024-10-24

candesartan and Peritoneal Carcinomatosis

candesartan has been researched along with Peritoneal Carcinomatosis in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
" The effects of AT1 receptor blocker candesartan were evaluated in a mouse model of peritoneal carcinomatosis."3.75Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin. ( Fujimura, T; Fujita, H; Fushida, S; Harada, S; Hirakawa, K; Kayahara, M; Kinami, S; Kinoshita, J; Ninomiya, I; Ohta, T; Yagi, Y; Yashiro, M, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinoshita, J1
Fushida, S1
Harada, S1
Yagi, Y1
Fujita, H1
Kinami, S1
Ninomiya, I1
Fujimura, T1
Kayahara, M1
Yashiro, M1
Hirakawa, K1
Ohta, T1

Other Studies

1 other study available for candesartan and Peritoneal Carcinomatosis

ArticleYear
Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin.
    International journal of oncology, 2009, Volume: 34, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Angiotensin II; A

2009